BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6598493)

  • 1. [Anti-atherosclerotic and antihypertensive agents (XI)].
    Eguchi Y; Sugimoto A; Ito S; Nakajima M; Kaneko S; Ishikawa M
    Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1984; 18():17-23. PubMed ID: 6598493
    [No Abstract]   [Full Text] [Related]  

  • 2. Some pyrrole substituted aryl pyridazinone and phthalazinone derivatives and their antihypertensive activities.
    Demirayak S; Karaburun AC; Beis R
    Eur J Med Chem; 2004 Dec; 39(12):1089-95. PubMed ID: 15571871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of 1-(1,4,5,6-tetrahydro-1,2,4-triazinyl)phthalazine derivatives possessing antihypertensive properties.
    Kolwas J
    Acta Pol Pharm; 1984; 41(4):405-10. PubMed ID: 6532132
    [No Abstract]   [Full Text] [Related]  

  • 4. [Synthesis studies on anti-atherosclerotic agents].
    Eguchi Y; Ishikawa M
    Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1985; 19():39-43. PubMed ID: 3869715
    [No Abstract]   [Full Text] [Related]  

  • 5. Pyridazine derivatives, VI. Synthesis and hypotensive activity of 3-hydrazinethieno(2,3-h)cinnoline and its derivatives.
    García-Dominguez N; Raviña E; Santana L; Terán C; García-Mera G; Orallo F; Crespo M; Fontenla JA
    Arch Pharm (Weinheim); 1988 Oct; 321(10):735-8. PubMed ID: 3240060
    [No Abstract]   [Full Text] [Related]  

  • 6. New 1(2H)-phthalazinones of potential antimicrobial activity.
    Kassem EM; Kamel MM; el-Zahar M
    Pharmazie; 1990 Mar; 45(3):215-6. PubMed ID: 2381966
    [No Abstract]   [Full Text] [Related]  

  • 7. [Phthalazinylides. Action of p-methoxyphenacyl bromide on 1-methylphthalazine].
    Caproşu M; Ungureanu M; Stavri N; Petrovanu M
    Rev Med Chir Soc Med Nat Iasi; 1986; 90(4):719-21. PubMed ID: 3602734
    [No Abstract]   [Full Text] [Related]  

  • 8. Possible effect of drugs on arterial wall metabolism in experimental atherosclerosis.
    Mrhová O; Urbanová D
    Czech Med; 1982; 5(3):165-75. PubMed ID: 6814877
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on vasoactive heterocyclic compounds. Preparation and evaluation of the hypotensive and antiaggregating activities of phthalazinol nitrates.
    Ito S; Komoda Y; Sekizaki S; Azuma H; Ishikawa M
    Chem Pharm Bull (Tokyo); 1988 Jul; 36(7):2669-72. PubMed ID: 3240486
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on antiatherosclerotic agents. IX. Synthesis of 7-ethoxycarbonyl-4-hydroxymethyl-6,8-dimethyl-1(2H)-phthalazinone (EG 626).
    Ishikawa M; Eguchi Y; Sugimoto A
    Chem Pharm Bull (Tokyo); 1980 Sep; 28(9):2770-8. PubMed ID: 7460102
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and pharmacological evaluation of N-(dimethylamino)ethyl derivatives of benzo- and pyridopyridazinones.
    Pakulska W; Malinowski Z; Szczesniak AK; Czarnecka E; Epsztajn J
    Arch Pharm (Weinheim); 2009 Jan; 342(1):41-7. PubMed ID: 19051195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synthetic studies of antiatherogenic agents. (VI) Syntheses of carbamate derivative of substituted phthalazinones (author's transl)].
    Eguchi Y; Ishikawa M
    Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1977; 11():49-53. PubMed ID: 284539
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on antiatherosclerotic agents. VII. Synthesis and structure-activity relationship of 4-hydroxymethyl-1(2H)-phthalazinone derivatives.
    Eguchi Y; Sugimoto A; Ishikawa M
    Chem Pharm Bull (Tokyo); 1980 Sep; 28(9):2763-9. PubMed ID: 7460101
    [No Abstract]   [Full Text] [Related]  

  • 14. Some recent approaches of biologically active substituted pyridazine and phthalazine drugs.
    Asif M
    Curr Med Chem; 2012; 19(18):2984-91. PubMed ID: 22519394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central nervous system stimulation & analeptic activity of 1-(1'-methyl pyrrolidine)-phthalaz-4-one (compound 78-788).
    Patnaik GK; Prasad CR; Mukherjee KC; Dhawan BN
    Indian J Exp Biol; 1981 Dec; 19(12):1195-6. PubMed ID: 6120894
    [No Abstract]   [Full Text] [Related]  

  • 16. [New pyridazine derivatives with physiological activity].
    Stefănescu E; Caproşu M; Gafiţanu E; Dăneţ R; Petrovanu M
    Rev Med Chir Soc Med Nat Iasi; 1979; 83(2):311-5. PubMed ID: 545610
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacological and toxicological investigation of 2,2-diethyl-2,3,5,10-tetrahydro-1H-pyrazolo(1,2-b)phthalazine-1,3-dione, a new compound with anti-inflammatory activity].
    Dalla Vedova R; Cadel S; D'Alò G
    Farmaco Sci; 1980 Jun; 35(6):474-80. PubMed ID: 7450041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthetic studies of antiatherogenic agents (13). Synthesis of phthalazinol analogues].
    Eguchi Y; Hasegawa Y; Katano E; Komoda Y; Ishikawa M
    Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1987; 21():27-33. PubMed ID: 3506241
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on antiatherosclerotic agents. Synthesis of 5-substituted derivatives of 7-ethoxycarbonyl-6,8-dimethyl-1(2H)-phthalazinone.off.
    Eguchi Y; Ishikawa M
    Chem Pharm Bull (Tokyo); 1991 Jul; 39(7):1846-8. PubMed ID: 1777938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-atherosclerotic agents. XIV. Mode of inhibitory action of TH016 on platelet aggregation.
    Ishikawa M; Kaneko S; Takashima Y; Tanaka H; Azuma H
    Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1987; 21():45-50. PubMed ID: 3506243
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.